Leaflet AGENERASE 150mg soft capsules
Indicated for: HIV-1 infection
Route of administration: oral
Substance: amprenavir (protease inhibitor)
ATC: J05AE05 (Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Amprenavir is an antiretroviral medication used in the treatment of human immunodeficiency virus (HIV) infection. It belongs to the class of protease inhibitors and works by blocking the HIV protease enzyme, which is essential for viral replication. By inhibiting this enzyme, amprenavir reduces viral load and helps maintain immune system function.
Amprenavir is administered orally, usually in combination with other antiretroviral medications as part of highly active antiretroviral therapy (HAART). The dosage and administration schedule are adjusted based on the patient's weight and response to treatment.
Common side effects include nausea, diarrhea, fatigue, skin rashes, and changes in blood lipid levels. In rare cases, severe adverse reactions such as allergic reactions or liver damage may occur.
Patients taking amprenavir should undergo regular monitoring for treatment efficacy and potential side effects. Additionally, the medication may interact with other drugs, requiring caution. Amprenavir is an important component of HIV treatment, contributing to improved quality of life for patients living with the virus.
General data about AGENERASE 150mg
- Substance: amprenavir
- Date of latest medicines list: 01-07-2013
- Product code: W08209004
- Concentration: 150mg
- Pharmaceutical form: soft capsules
- Quantity: 960
- Product type: Original
- Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Pharmaceutical forms available for amprenavir
Concentrations available for amprenavir
- 150mg
- 15mg/ml
- 50mg